← Who reports today · Health Care
TECH earnings date & Q4 FY2026 results · Bio-Techne
US GAAP · $M · vs Q4 FY2025 · quarter ended 06/30/2026 (fiscal year is shifted) · reported 08/12/2026
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. · Text: Wikipedia, CC BY-SA 4.0, abridged
When is TECH’s next earnings date?
Wednesday, November 4, 2026estimated
Expected around Nov 4 — based on last year’s report on Nov 5, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once TECH announces it.
Same quarter a year ago (ended September 30, 2025): revenue $286.6M, EPS (GAAP) $0.24
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does TECH report? Usually before market open: the last 4 results releases reached the SEC at 6:30 am, 6:30 am, 6:30 am, 6:31 am ET.
Last report: Aug 12, 2026 (Q4 FY2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$321
+1.3%
Gross profit
$211
+6.3%
65.8% margin
Operating income
$74.3
23.1% margin
Net income
$54.6
$0.35/sh · 17.0% margin
Verdict: revenue grew 1.3% y/y to $321M, operating margin 23.1% vs 7.5%, net income $55M.
Bio-Techne agreed to be acquired by Merck KGaA for $73 per share in cash, an enterprise value of approximately $11.3 billion.
Source and notation
Source: Bio-Techne press release, 8-K EX-99.1 of 08/12/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
TECH earnings history: past report dates
| Aug 12, 2026 Wed | 6:30 ambefore market open | Jun 30, 2026 | ≈$321M+1% y/y | ≈$0.36 |
| May 6, 2026 Wed | 6:30 ambefore market open | Mar 31, 2026 | $311M−2% y/y | $0.32+129% y/y |
| Feb 4, 2026 Wed | 6:30 ambefore market open | Dec 31, 2025 | $296M−0% y/y | $0.24+9% y/y |
| Nov 5, 2025 Wed | 6:31 ambefore market open | Sep 30, 2025 | $287M−1% y/y | $0.24+14% y/y |
| Aug 6, 2025 Wed | 6:30 ambefore market open | Jun 30, 2025 | ≈$317M+4% y/y | ≈−$0.11 |
| May 7, 2025 Wed | 6:30 ambefore market open | Mar 31, 2025 | $316M+4% y/y | $0.14−55% y/y |
| Feb 5, 2025 Wed | 6:30 ambefore market open | Dec 31, 2024 | $297M+9% y/y | $0.22+29% y/y |
| Oct 30, 2024 Wed | 6:30 ambefore market open | Sep 30, 2024 | $289M+5% y/y | $0.21−32% y/y |
| Aug 7, 2024 Wed | 6:32 ambefore market open | Jun 30, 2024 | ≈$306M+2% y/y | ≈$0.26−43% y/y |
| May 1, 2024 Wed | 6:30 ambefore market open | Mar 31, 2024 | $303M+3% y/y | $0.31−28% y/y |
| Feb 1, 2024 Thu | 6:30 ambefore market open | Dec 31, 2023 | $273M+0% y/y | $0.17−45% y/y |
| Oct 31, 2023 Tue | 6:30 ambefore market open | Sep 30, 2023 | $277M+3% y/y | $0.31−44% y/y |
| Aug 8, 2023 Tue | 6:30 ambefore market open | Jun 30, 2023 | ≈$301M+5% y/y | ≈$0.46+21% y/y |
| May 3, 2023 Wed | 6:30 ambefore market open | Mar 31, 2023 | $294M+1% y/y | $0.43+16% y/y |
| Feb 2, 2023 Thu | 6:31 ambefore market open | Dec 31, 2022 | $272M+1% y/y | $0.31−37% y/y |
| Nov 1, 2022 Tue | 6:32 ambefore market open | Sep 30, 2022 | $270M+5% y/y | $0.55+31% y/y |
| Aug 4, 2022 Thu | 6:30 ambefore market open | Jun 30, 2022 | ≈$288M+11% y/y | ≈$0.38+322% y/y |
| May 4, 2022 Wed | 6:35 ambefore market open | Mar 31, 2022 | $290M+19% y/y | $0.37+32% y/y |
| Feb 1, 2022 Tue | 6:30 ambefore market open | Dec 31, 2021 | $269M+20% y/y | $0.49+69% y/y |
| Nov 2, 2021 Tue | 6:30 ambefore market open | Sep 30, 2021 | $258M+26% y/y | $0.42+100% y/y |
| Aug 5, 2021 Thu | 6:32 ambefore market open | Jun 30, 2021 | ≈$259M+47% y/y | ≈$0.09−76% y/y |
| May 6, 2021 Thu | 6:33 ambefore market open | Mar 31, 2021 | $244M+25% y/y | $0.28+22% y/y |
| Feb 2, 2021 Tue | 6:34 ambefore market open | Dec 31, 2020 | $224M+21% y/y | $0.29−62% y/y |
| Nov 5, 2020 Thu | 6:32 ambefore market open | Sep 30, 2020 | $204M+11% y/y | $0.21+133% y/y |
| Aug 4, 2020 Tue | 6:30 ambefore market open | Jun 30, 2020 | ≈$176M−8% y/y | ≈$0.37+236% y/y |
| Apr 30, 2020 Thu | 6:35 ambefore market open | Mar 31, 2020 | $195M+5% y/y | $0.23−21% y/y |
| Feb 4, 2020 Tue | 6:31 ambefore market open | Dec 31, 2019 | $185M+6% y/y | $0.76+591% y/y |
| Oct 29, 2019 Tue | 6:33 ambefore market open | Sep 30, 2019 | $183M+12% y/y | $0.09−18% y/y |
| Aug 6, 2019 Tue | 6:32 ambefore market open | Jun 30, 2019 | ≈$192M+6% y/y | ≈$0.11−59% y/y |
| Apr 30, 2019 Tue | 6:32 ambefore market open | Mar 31, 2019 | $185M+13% y/y | $0.29+123% y/y |
| Feb 5, 2019 Tue | 6:30 ambefore market open | Dec 31, 2018 | $175M+13% y/y | $0.11−66% y/y |
| Oct 30, 2018 Tue | 6:55 ambefore market open | Sep 30, 2018 | $163M+13% y/y | $0.11+0% y/y |
| Aug 7, 2018 Tue | 7:01 ambefore market open | Jun 30, 2018 | ≈$180M+15% y/y | ≈$0.27+42% y/y |
| May 2, 2018 Wed | 7:01 ambefore market open | Mar 31, 2018 | $164M+14% y/y | $0.13−13% y/y |
| Feb 6, 2018 Tue | 7:31 ambefore market open | Dec 31, 2017 | $154M+17% y/y | $0.32+540% y/y |
| Oct 31, 2017 Tue | 7:32 ambefore market open | Sep 30, 2017 | $145M+11% y/y | $0.11−15% y/y |
| Aug 8, 2017 Tue | 7:30 ambefore market open | Jun 30, 2017 | $157M+16% y/y | $0.19+12% y/y |
| May 2, 2017 Tue | 7:33 ambefore market open | Mar 31, 2017 | $144M+10% y/y | $0.15−25% y/y |
| Feb 7, 2017 Tue | 7:30 ambefore market open | Dec 31, 2016 | $132M+9% y/y | $0.05−71% y/y |
| Oct 31, 2016 Mon | 8:30 ambefore market open | Sep 30, 2016 | $131M+16% y/y | $0.13−13% y/y |
| Aug 17, 2016 Wed | 2:46 pmduring market hours | Jun 30, 2016 | $135M+15% y/y | $0.17−6% y/y |
| May 3, 2016 Tue | 7:00 ambefore market open | Mar 31, 2016 | $131M+15% y/y | $0.20+25% y/y |
| Feb 2, 2016 Tue | 9:01 ambefore market open | Dec 31, 2015 | $121M+8% y/y | $0.17−23% y/y |
| Oct 28, 2015 Wed | 9:31 amduring market hours | Sep 30, 2015 | $112M+4% y/y | $0.15−6% y/y |
| Aug 6, 2015 Thu | 8:00 ambefore market open | Jun 30, 2015 | ≈$118M+27% y/y | ≈$0.18+0% y/y |
| May 5, 2015 Tue | 7:30 ambefore market open | Mar 31, 2015 | $114M+19% y/y | $0.16−24% y/y |
| Feb 3, 2015 Tue | 7:01 ambefore market open | Dec 31, 2014 | $112M+33% y/y | $0.22+29% y/y |
| Oct 28, 2014 Tue | 8:30 ambefore market open | Sep 30, 2014 | $108M+27% y/y | $0.16−16% y/y |
| Aug 11, 2014 Mon | 8:31 ambefore market open | Jun 30, 2014 | ≈$93M+16% y/y | ≈$0.18−5% y/y |
| Apr 30, 2014 Wed | 7:00 ambefore market open | Mar 31, 2014 | $96M+18% y/y | $0.21−9% y/y |
| Feb 4, 2014 Tue | 9:45 amduring market hours | Dec 31, 2013 | $84M+12% y/y | $0.17+0% y/y |
| Oct 29, 2013 Tue | 8:15 ambefore market open | Sep 30, 2013 | $86M+14% y/y | $0.19+6% y/y |
| Aug 6, 2013 Tue | 8:56 ambefore market open | Jun 30, 2013 | ≈$79M+1% y/y | ≈$0.19+0% y/y |
| Apr 30, 2013 Tue | 9:25 ambefore market open | Mar 31, 2013 | $81M−3% y/y | $0.23+5% y/y |
| Feb 5, 2013 Tue | 10:25 amduring market hours | Dec 31, 2012 | $75M+1% y/y | $0.17−6% y/y |
| Oct 23, 2012 Tue | 10:43 amduring market hours | Sep 30, 2012 | $75M−3% y/y | $0.18−5% y/y |
| Jul 31, 2012 Tue | 8:57 ambefore market open | Jun 30, 2012 | ≈$79M+1% y/y | ≈$0.19+0% y/y |
| May 1, 2012 Tue | 9:04 ambefore market open | Mar 31, 2012 | $84M+10% y/y | $0.22+5% y/y |
| Jan 31, 2012 Tue | 9:11 ambefore market open | Dec 31, 2011 | $75M | $0.18 |
| Oct 25, 2011 Tue | 9:15 ambefore market open | Sep 30, 2011 | $78M | $0.19 |
| Aug 2, 2011 Tue | 9:06 ambefore market open | Jun 30, 2011 | ≈$78M | ≈$0.19 |
| May 3, 2011 Tue | 8:47 ambefore market open | Mar 31, 2011 | $76M | $0.21 |
Show all 62 reports since 2011Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Bio-Techne: 16-year financials
| FY2026 | 1,215 | 252 | 182 | 263 | 49.9 |
| FY2025 | 1,220 | 102 | 73.4 | 257 | 50.4 |
| FY2024 | 1,159 | 207 | 168 | 236 | 50.4 |
| FY2023 | 1,137 | 299 | 285 | 216 | 50.3 |
| FY2022 | 1,106 | 297 | 272 | 280 | 50.2 |
| FY2021 | 931 | 237 | 140 | 308 | 49.6 |
| FY2020 | 739 | 157 | 229 | 154 | 48.9 |
| FY2019 | 714 | 147 | 96.1 | 156 | 48.4 |
| FY2018 | 643 | 136 | 126 | 149 | 48 |
| FY2017 | 563 | 121 | 76.1 | 129 | 47.3 |
| FY2016 | 499 | 151 | 105 | 127 | 47.6 |
| FY2015 | 452 | 147 | 108 | 120 | 47.1 |
| FY2014 | 358 | 160 | 111 | 123 | 45.4 |
| FY2013 | 311 | 159 | 113 | 101 | 43.5 |
| FY2012 | 315 | 166 | 112 | 121 | 41 |
| FY2011 | 290 | 163 | 112 | 124 | 39.7 |
Show all 16 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*; the company’s fiscal year doesn’t match the calendar year so years follow the company’s own labels.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $2.1B (82% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with no net debt · S&P 500 companies that paid dividends 10 years without a gap · Piotroski F-score: S&P 500 companies scoring 8 or 9
Bio-Techne (TECH) earnings: FAQ
When is TECH's next earnings date?
We have not yet seen an announcement of the date from Bio-Techne (TECH). Based on last year's report on Nov 5, 2025, the next report is expected around Nov 4, 2026.
What time does TECH report earnings?
Bio-Techne usually reports before market open: its latest results release was filed with the SEC at 6:30 am ET on Aug 12, 2026.
When did TECH last report earnings?
Bio-Techne reported Q4 FY2026 results on Aug 12, 2026.
Where can I find Bio-Techne's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to TECH's filings; this page breaks the latest report down in a Sankey chart.
What was TECH's net income in Q4 FY2026?
Bio-Techne reported net income of $54.6M for Q4 FY2026 (vs −$17.7 year over year), under US GAAP.
Does Bio-Techne pay dividends?
Yes. In fiscal 2026, Bio-Techne paid $50M in dividends on its common stock, per its 10-K. Earlier years are in the 16-year table above.
How has Bio-Techne's revenue changed since 2011?
Per its 10-K filings, revenue grew 4.2x: $290M in fiscal 2011 and $1,215M in fiscal 2026. The peak was $1,220M in fiscal 2025. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: TMO · Q2 2026 · UHS · Q2 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q2 2026 · ZBH · Q2 2026 · A · Q3 FY2026 · ABBV · Q2 2026 · ABT · Q2 2026 · ALGN · Q2 2026 · all reports